Health News Roundup: Australia orders study on mental health; Bausch Health's lotion gets FDA approval

Conflicts in Iraq and Afghanistan may have led to an increase in rates of post-traumatic stress disorder (PTSD), according to new research looking at the mental health of Britain's soldiers.

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Bausch Health Cos Inc, formerly known as Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali. The company plans to launch the lotion in November after receiving final approval from the Food and Drug Administration, pending expiration of exclusivity for a related product.

Australia launches an inquiry into mental health's impact on productivity

Australia has commissioned an inquiry into the impact mental illness has on economic productivity, the government said on Sunday. The 18-month inquiry by the country's Productivity Commission will provide recommendations on how to improve the social and economic participation of Australians struggling with their mental health.